CAS No. |
2245073-05-4 |
中文名称 |
((4R,7S,10S,13S,16S,19R)-19-((S)-4-氨基-2-((S)-2-((S)-6-氨基-2-((S)-2-((S)-2-氨基-4-甲基戊酰氨基)-5-胍基戊酰氨基)己酰氨基)-3-(1H-咪唑-4-基)丙酰氨基)-4-氧代丁酰氨基)-13-(3-氨基-3-氧代丙基)-7,10-双(3-胍基丙基)-16-异丁基-6,9,12,15,18-五氧代-1,2-二硫杂-5,8,11,14,17-五氮杂二十元环-4-羰基)-L-甲硫氨酰-L-脯氨酰-L-亮氨酰-L-组氨酰-L-丝氨酰-L-精氨酰-L-缬氨酰-L-脯氨酰-L-苯丙氨酰-L-脯氨酸 |
英文名称 |
((4R,7S,10S,13S,16S,19R)-19-((S)-4-amino-2-((S)-2-((S)-6-amino-2-((S)-2-((S)-2-amino-4-methylpentanamido)-5-guanidinopentanamido)hexanamido)-3-(1H-imidazol-4-yl)propanamido)-4-oxobutanamido)-13-(3-amino-3-oxopropyl)-7,10-bis(3-guanidinopropyl)-16-isobutyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-methionyl-L-prolyl-L-leucyl-L-histidyl-L-seryl-L-arginyl-L-valyl-L-prolyl-L-phenylalanyl-L-proline |
别名 |
(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(4R,7S,10S,13S,16S,19R)-19-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-oxobutanoyl]amino]-13-(3-amino-3-oxopropyl)-7,10-bis(3-carbamimidamidopropyl)-16-(2-methylpropyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-4-methylsulfanylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid |
标准英文名 |
((4R,7S,10S,13S,16S,19R)-19-((S)-4-amino-2-((S)-2-((S)-6-amino-2-((S)-2-((S)-2-amino-4-methylpentanamido)-5-guanidinopentanamido)hexanamido)-3-(1H-imidazol-4-yl)propanamido)-4-oxobutanamido)-13-(3-amino-3-oxopropyl)-7,10-bis(3-guanidinopropyl)-16-isobutyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-methionyl-L-prolyl-L-leucyl-L-histidyl-L-seryl-L-arginyl-L-valyl-L-prolyl-L-phenylalanyl-L-proline |
分子式 |
C112H184N40O25S3 |
分子量 |
2587.16
|
精确分子量 |
2585.35
|
SMILES |
CSCC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C |
标准SMILES |
CSCC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(O)=O |
用途 |
ELA-21 (human) is an apelin receptor agonist with a pKi of 8.52; it fully inhibits forskolin-induced cAMP production and stimulates β-arrestin recruitment at sub-nanomolar potency; it acts as an agonist in both G protein-dependent and -independent signaling pathways. |
InChIKey |
DITOSSSIQUUZEP-FMGZCOAKSA-N |